Hypofractionated LocoRegional Radiotherapy in Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Timothy Whelan, MD
Juravinski Cancer Centre, McMaster University, Hamilton
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tom Baker Cancer Centre
Calgary, Alberta, Canada
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Bc Cancer - Centre for the Southern Interior
Kelowna, British Columbia, Canada
- Bc Cancer - Centre for the North
Prince George, British Columbia, Canada
- Bc Cancer - Vancouver Centre
Vancouver, British Columbia, Canada
- Bc Cancer - Vancouver Island Centre
Victoria, British Columbia, Canada
- Northeast Cancer Centre, Health Sciences North
Greater Sudbury, Ontario, Canada
- Juravinski Cancer Centre
Hamilton, Ontario, Canada
- London Regional Cancer Program
London, Ontario, Canada
- the Ottawa Hospital Regional Cancer Centre
Ottawa, Ontario, Canada
- Princess Margaret Cancer Centre - Uhn
Toronto, Ontario, Canada
- Sunnybrook Health Sciences Centre - Odette Cancer Centre
Toronto, Ontario, Canada
- Hotel-Dieu de Lévis (cisss Ca)
Lévis, Quebec, Canada
- Chum - Centre Hospitalier de L'Universite de Montreal
Montreal, Quebec, Canada
- Ciusss de L'Est-de-L'Île de Montréal, Hôpital, Maisonneuve-Rosemont
Montreal, Quebec, Canada
- Mcgill University Health Centre-Cedars Cancer Centre
Montreal, Quebec, Canada
- Chu-de Québec-Université de Laval
Québec, Quebec, Canada
- Sherbrooke University Hospital Centre
Sherbrooke, Quebec, Canada
- Allan Blair Cancer Centre
Regina, Saskatchewan, Canada
- Saskatoon Cancer Centre
Saskatoon, Saskatchewan, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Feb 2021
- Primary completion
- 31 Jul 2028
- Completion
- 31 Dec 2030
- Last update posted
- 17 Jun 2026
- Registered enrollment
- 588
- Registry id
- NCT04228991
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.